Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDPH.L Regulatory News (DPH)

  • There is currently no data for DPH

Form 8.3 - Dechra Pharmaceuticals plc

19 Dec 2023 14:11

RNS Number : 3466X
Barclays PLC
19 December 2023
Ā 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Ā 

Barclays PLC.

(b)

Owner or controller of interest and short

Ā 

Ā 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DECHRA PHARMACEUTICALS PLC

Ā 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Ā 

Ā 

offeror/offeree, state this and specify identity of

Ā 

offeror/offeree:

(e)

Date position held/dealing undertaken:

18 Dec 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Ā 

Ā 

Ā 

disclosures in respect of any other party to the offer?

Ā 

Ā 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Ā 

Ā 

to which the disclosure relates following the dealing(if any)

Ā 

Class of relevant security:

1p ordinary

Ā 

Interests

Short Positions

Ā 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Ā 

Ā 

Ā 

Ā 

Ā 

and/or controlled:

Ā 

Ā 

8,007,239

7.03%

2,622,558

2.30%

(2)

Cash-settled derivatives:

Ā 

Ā 

Ā 

Ā 

Ā 

and/or controlled:

Ā 

Ā 

910,190

0.80%

7,936,891

6.97%

(3)

Stock-settled derivatives (including options)

Ā 

Ā 

Ā 

Ā 

Ā 

and agreements to purchase/sell:

Ā 

Ā 

0

0.00%

0

0.00%

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

TOTAL:

Ā 

Ā 

8,917,429

7.83%

10,559,449

9.27%

(b)

Rights to subscribe for new securities (including directors and other executive

Ā 

Ā 

options)

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant security in relation to

Ā 

Ā 

Ā 

Ā 

which subscription right exists

Ā 

Ā 

Ā 

Ā 

Details, including nature of the rights

Ā 

Ā 

Ā 

Ā 

concerned and relevant percentages:

Ā 

Ā 

Ā 

Ā 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Ā 

securities

Ā 

1p ordinary

Purchase

300,000

38.4792 GBP

1p ordinary

Purchase

100,000

38.4392 GBP

1p ordinary

Purchase

27,100

38.4500 GBP

1p ordinary

Purchase

26,872

38.4612 GBP

1p ordinary

Purchase

25,000

38.4592 GBP

1p ordinary

Purchase

11,305

38.4581 GBP

1p ordinary

Purchase

6,627

38.4577 GBP

1p ordinary

Purchase

5,390

38.4578 GBP

1p ordinary

Purchase

3,614

38.4626 GBP

1p ordinary

Purchase

2,725

38.4473 GBP

1p ordinary

Purchase

2,255

38.4600 GBP

1p ordinary

Purchase

1,524

38.4891 GBP

1p ordinary

Purchase

1,054

38.4700 GBP

1p ordinary

Purchase

651

38.4336 GBP

1p ordinary

Purchase

602

38.4200 GBP

1p ordinary

Purchase

454

38.4400 GBP

1p ordinary

Purchase

14

38.4800 GBP

1p ordinary

Sale

29,797

38.4512 GBP

1p ordinary

Sale

8,297

38.4000 GBP

1p ordinary

Sale

7,747

38.4600 GBP

1p ordinary

Sale

3,216

38.4580 GBP

1p ordinary

Sale

1,208

38.4971 GBP

1p ordinary

Sale

1,174

38.4995 GBP

1p ordinary

Sale

929

38.3950 GBP

1p ordinary

Sale

485

38.4561 GBP

1p ordinary

Sale

413

38.4700 GBP

1p ordinary

Sale

122

38.4400 GBP

1p ordinary

Sale

106

38.4200 GBP

1p ordinary

Sale

97

38.4729 GBP

1p ordinary

Sale

25

38.4211 GBP

1p ordinary

Sale

14

38.4800 GBP

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(b)

Cash-settled derivative transactions

Ā 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Ā 

reference

unit

security

Ā 

Ā 

securities

Ā 

1p ordinary

SWAP

Decreasing Long

118

38.4400 GBP

1p ordinary

SWAP

Decreasing Long

1,580

38.4461 GBP

1p ordinary

SWAP

Decreasing Long

5,086

38.4517 GBP

1p ordinary

SWAP

Decreasing Long

10,356

38.4600 GBP

1p ordinary

SWAP

Decreasing Short

485

38.4561 GBP

1p ordinary

SWAP

Decreasing Short

1,853

38.4685 GBP

1p ordinary

SWAP

Decreasing Short

2,270

38.4969 GBP

1p ordinary

SWAP

Decreasing Short

2,816

38.4141 GBP

1p ordinary

SWAP

Decreasing Short

7,497

38.4000 GBP

1p ordinary

SWAP

Increasing Short

15

38.4238 GBP

1p ordinary

SWAP

Increasing Short

18

38.4316 GBP

1p ordinary

SWAP

Increasing Short

84

38.4600 GBP

1p ordinary

SWAP

Increasing Short

214

38.4400 GBP

1p ordinary

SWAP

Increasing Short

1,069

38.4497 GBP

1p ordinary

SWAP

Increasing Short

5,411

38.4697 GBP

1p ordinary

SWAP

Increasing Short

5,433

38.4642 GBP

1p ordinary

SWAP

Increasing Short

10,225

38.4599 GBP

1p ordinary

SWAP

Increasing Short

11,272

38.4582 GBP

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(c)

Stock-settled derivative transactions (including options)

Ā 

(i)

Writing, selling, purchasing or varying

Ā 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Ā 

date

money

relevant

Ā 

selling,

securities

per unit

Ā 

Ā 

paid/

security

Ā 

varying etc

to which

Ā 

Ā 

Ā 

received

Ā 

Ā 

Ā 

option

Ā 

Ā 

Ā 

per unit

Ā 

Ā 

Ā 

relates

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(ii)

Exercising

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Ā 

Ā 

securities

unit

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

(d)

Other dealings (including subscribing for new securities)

Ā 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Ā 

Ā 

applicable)

Ā 

Ā 

Ā 

Ā 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Ā 

Details of any indemnity or option arrangement, or any agreement or understanding,

Ā 

Ā 

formal or informal, relating to relevant securities which may be an inducement to deal

Ā 

Ā 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Ā 

to the offer or any person acting in concert with a party to the offer:

Ā 

Ā 

Ā 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Ā 

Details of any agreement, arrangement or understanding, formal or informal, between

Ā 

Ā 

the person making the disclosure and any other person relating to:

Ā 

Ā 

(i) the voting rights of any relevant securities under any option; or

Ā 

Ā 

Ā 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Ā 

Ā 

any derivative is referenced:

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

NONE

(c)

Attachments

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

19 Dec 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

Ā 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Ā 
END
Ā 
Ā 
RETEALANFEPDFFA
Date   Source Headline
16th Jan 20244:54 pmRNSHolding(s) in Company
16th Jan 20243:29 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20242:43 pmRNSHolding(s) in Company
16th Jan 20241:25 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:15 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20241:02 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
16th Jan 202412:50 pmRNSForm 8.5 (EPT/RI)-Replacement of Dechra
16th Jan 202412:44 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 202412:04 pmRNSHolding(s) in Company
16th Jan 202410:15 amRNSScheme of Arrangement becomes Effective
16th Jan 202410:11 amRNSForm 8.5 (EPT/NON-RI) - Dechra Pharmaceuticals PLC
16th Jan 202410:11 amRNSForm 8.5 (EPT/RI)
16th Jan 20249:20 amRNSForm 8.3 - Dechra Pharmaceuticals plc
16th Jan 20249:04 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
16th Jan 20249:00 amRNSHolding(s) in Company
16th Jan 20248:12 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
16th Jan 20247:39 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
16th Jan 20247:30 amRNSSuspension - Dechra Pharmaceuticals PLC
15th Jan 20244:51 pmRNSDirector/PDMR Shareholding
15th Jan 20243:51 pmRNSHolding(s) in Company
15th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20243:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:57 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20241:46 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
15th Jan 202412:35 pmGNWForm 8.3 - Dechra Pharmaceuticals PLC
15th Jan 202412:05 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:51 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 202411:25 amRNSForm 8.5 (EPT/NON-RI) Dechra Pharmaceuticals Plc
15th Jan 20249:58 amRNSForm 8.5 (EPT/NON-RI)
15th Jan 20249:58 amRNSForm 8.5 (EPT/RI)
15th Jan 20249:31 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
15th Jan 20249:13 amRNSForm 8.3 - Dechra Pharmaceuticals plc
15th Jan 20247:29 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc
12th Jan 20244:02 pmRNSCourt sanction of Scheme of Arrangement
12th Jan 20243:30 pmGNWForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:20 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20243:07 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:42 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20242:30 pmRNSHolding(s) in Company
12th Jan 20241:38 pmEQSForm 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
12th Jan 20241:24 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202412:03 pmRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 202410:39 amGNWForm 8.3 - Dechra Pharmaceuticals PLC
12th Jan 202410:39 amRNSForm 8.5 (EPT/RI)
12th Jan 202410:36 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 202410:35 amRNSForm 8.3 - Dechra Pharmaceuticals plc
12th Jan 20249:34 amRNSHolding(s) in Company
12th Jan 20249:22 amRNSForm 8.5 (EPT/RI)-Dechra Pharmaceuticals plc
12th Jan 20248:09 amGNWForm 8.5 (EPT/RI) - Dechra Pharmaceuticals plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.